Prevalence and clinical features of hedonistic homeostatic dysregulation in Parkinson's disease
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Hedonistic homeostatic dysregulation (HHD) is a neuropsychiatric disorder recently described in Parkinson's disease (PD), which is characterized by self‐medication and addiction to dopaminergic drugs. To understand the prevalence of this disorder, we screened 202 PD patients attending our movement disorder unit for HHD. The clinical features of the patients identified as affected by this syndrome were then compared with those of control PD patients in an attempt to ascertain the possible risk factors for HHD. Results showed 7 subjects who fulfilled the HHD criteria. The analysis of a case–control study showed a significant correlation between HHD and a previous history of mood disorders, and the use of dopamine agonists, either in monotherapy or in combination. The prevalence of HHD in our study is similar to the one reported in the United Kingdom by the authors who first described this syndrome in PD. Of interest, our patients showed a somewhat different pattern of the disorder, suggesting that cultural and environmental factors may play a role in the phenomenology of HHD. © 2004 Movement Disorder Society
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Parkinsonism: onset, progression, and mortality
Hoehn, M. M., & Yahr, M. D. (1967) · Neurology · doi:10.1212/wnl.17.5.427 · Cited by 12,107
Getting formal with dopamine and reward
Schultz, W. (2002) · Neuron · doi:10.1016/s0896-6273(02)00967-4 · Cited by 2,574
Cited by
Non-motor symptoms of Parkinson's disease: diagnosis and management
Chaudhuri, K. R., Healy, D. G., & Schapira, A. H. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70373-8 · Cited by 2,807
Motor fluctuations and dyskinesias in Parkinson's disease: Clinical manifestations
Jankovic, J. (2005) · Movement Disorders · doi:10.1002/mds.20458 · Cited by 547
Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease
Bastide, M. F., Meissner, W. G., Picconi, B., Fasano, S., Fernagut, P.-O., Feyder, M., Francardo, V., Alcacer, C., Ding, Y., Brambilla, R., et al. (2015) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.07.002 · Cited by 475
Prevalence of repetitive and reward-seeking behaviors in Parkinson disease
Voon, V., Hassan, K., Zurowski, M., de Souza, M., Thomsen, T., Fox, S., Lang, A. E., & Miyasaki, J. (2006) · Neurology · doi:10.1212/01.wnl.0000238503.20816.13 · Cited by 418
Dopamine Agonist Withdrawal Syndrome in Parkinson Disease
Rabinak, C. A., & Nirenberg, M. J. (2010) · Archives of Neurology · doi:10.1001/archneurol.2009.294 · Cited by 349
Voon, V., Fernagut, P.-O., Wickens, J., Baunez, C., Rodriguez, M., Pavon, N., Juncos, J. L., Obeso, J. A., & Bezard, E. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70287-x · Cited by 335
Klos, K. J., Bower, J. H., Josephs, K. A., Matsumoto, J. Y., & Ahlskog, J. E. (2005) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2005.06.005 · Cited by 283
Diagnosis, Assessment, and Treatment of Hypersexuality
Kaplan, M. S., & Krueger, R. B. (2010) · The Journal of Sex Research · doi:10.1080/00224491003592863 · Cited by 267
Dopamine Dysregulation Syndrome: An Overview of its Epidemiology, Mechanisms and Management
OʼSullivan, S. S., Evans, A. H., & Lees, A. J. (2009) · CNS Drugs · doi:10.2165/00023210-200923020-00005 · Cited by 265
Compulsive eating and weight gain related to dopamine agonist use
Nirenberg, M. J., & Waters, C. (2006) · Movement Disorders · doi:10.1002/mds.20757 · Cited by 262
Lim, S.-Y., O’Sullivan, S. S., Kotschet, K., Gallagher, D. A., Lacey, C., Lawrence, A. D., Lees, A. J., O’Sullivan, D. J., Peppard, R. F., Rodrigues, J. P., et al. (2009) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2008.12.010 · Cited by 240
Impulsive and compulsive behaviors in Parkinson's disease
Evans, A. H., Strafella, A. P., Weintraub, D., & Stacy, M. (2009) · Movement Disorders · doi:10.1002/mds.22505 · Cited by 233
Levodopa in the Treatment of Parkinson's Disease: Current Status and New Developments
Salat, D., & Tolosa, E. (2013) · Journal of Parkinson’s Disease · doi:10.3233/jpd-130186 · Cited by 232
“Its frequency has been estimated to be 3–4% [58], but these figures may be an underestimation, as the mildest cases are rarely diagnosed.”
BackgroundFactors influencing susceptibility to compulsive dopaminergic drug use in Parkinson disease
Evans, A. H., Lawrence, A. D., Potts, J., Appel, S., & Lees, A. J. (2005) · Neurology · doi:10.1212/01.wnl.0000184487.72289.f0 · Cited by 210
Dopamine dysregulation syndrome in Parkinson’s disease: a systematic review of published cases
Warren, N., O’Gorman, C., Lehn, A., & Siskind, D. (2017) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2017-315985 · Cited by 172
The nonmotor symptoms of Parkinson's disease—An overview
Lim, S., & Lang, A. E. (2010) · Movement Disorders · doi:10.1002/mds.22786 · Cited by 171
“complicated by the dopamine dysregulation syndrome (DDS), in which patients develop a harmful pattern of excessive and compulsive dopaminergic drug use.(83,84)”
BackgroundKlaming, L., & Haselager, P. (2013) · Neuroethics · doi:10.1007/s12152-010-9093-1 · Cited by 166
“For instance, Levodopa, which is frequently prescribed to PD patients, may cause “hedonistic homeostatic dysregulation syndrome” resulting for instance in inadequate impulse control [57], which may in turn make the patient behave in a way that causes damage.”
BackgroundGiladi, N., Weitzman, N., Schreiber, S., Shabtai, H., & Peretz, C. (2007) · Journal of Psychopharmacology · doi:10.1177/0269881106073109 · Cited by 164
A systematic review of impulse control disorders in Parkinson’s disease.
Callesen, M. B., Scheel-Krüger, J., Kringelbach, M. L., & Møller, A. (2013) · Journal of Parkinson s Disease · doi:10.3233/jpd-120165 · Cited by 130
“It is important in this regard to emphasize that the detection of ICDs relies very much on caregivers, who play an important role in the daily medical care and supervision of psychiatric symptoms following withdrawal of dopamine agonists [53, 98, 216, 218].”
BackgroundCeravolo, R., Frosini, D., Rossi, C., & Bonuccelli, U. (2010) · Journal of Neurology · doi:10.1007/s00415-010-5715-0 · Cited by 41
Metadata
- Authors
- Romana Pezzella, F., Colosimo, C., Vanacore, N., Di Rezze, S., Chianese, M., Fabbrini, G., & Meco, G.
- Venue
- Movement Disorders
- Publisher
- Wiley
- Published
- 2004-08-17
- Volume
- 20
- Issue
- 1
- Pages
- 77-81
- ISSN
- 0885-3185 (ISSN-L)
- 1531-8257
- OpenAlex
- W2006932901
- Cited by
- 154
- References
- 2
- FWCI
- 6.96
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.